NCT04562649

Brief Summary

The overall goal of this study is to evaluate the effects of the CHAMPS intervention for people living with HIV (PLWH) in a randomized controlled trial. The proposed trial is scientifically significant in representing a principled and systematic effort to test the efficacy of a combined community health worker (CHW) and smartphone intervention linked to a smart pill box for antiretroviral (ART) adherence in PLWH in the United States (US). Guided by a rigorous theoretical model of supportive accountability and building on preliminary work, this intervention has the potential to enable PLWH to self-manage their ART regimens while CHW monitor their ART adherence in real-time ultimately leading to viral suppression and ART adherence.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 24, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

May 3, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 19, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 19, 2024

Completed
10 months until next milestone

Results Posted

Study results publicly available

February 17, 2025

Completed
Last Updated

February 17, 2025

Status Verified

January 1, 2025

Enrollment Period

3 years

First QC Date

September 18, 2020

Results QC Date

January 30, 2025

Last Update Submit

January 30, 2025

Conditions

Keywords

ARTPLWH

Outcome Measures

Primary Outcomes (1)

  • Number of Virally Suppressed Participants

    The number of virally suppressed participants. Viral suppression defined as viral load of \<200 copies/mL.

    6 month follow up, 12 month follow up

Secondary Outcomes (2)

  • Antiretroviral Therapy (ART) Adherence - CleverCap

    Up to 12 months

  • Change in Score on the Self-Rating Scale Item (SRSI)

    6 month follow up and 12 month follow up

Study Arms (2)

Intervention

EXPERIMENTAL

Wise App that delivers medication adherence reminders and community health worker sessions

Device: Wise App with medication adherence remindersBehavioral: CHW Sessions

Control

NO INTERVENTION

Standard of care

Interventions

The Intervention group will receive the Wise App that delivers medication adherence reminders.

Intervention
CHW SessionsBEHAVIORAL

The Intervention group will complete sessions with a community health worker (CHW).

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be able to communicate and read in English or Spanish
  • Willing to participate in any assigned arm of the intervention
  • Diagnosed with HIV ≥6 months ago
  • Have an HIV-1 RNA level \>200 copies/mL, or have at least one "no-show" visit in the past 12 months, or report being virally unsuppressed in the past 12 months
  • Have ART adherence \<80%, as measured through Single-Item Self-Rating Adherence Scale (SRSI)
  • Own a smartphone

You may not qualify if:

  • Reside in a nursing home, prison, and/or receiving in-patient psychiatric care at time of enrollment
  • Terminal illness with life expectancy \<6 months
  • Planning to move out of the area in the next 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Birmingham AIDS Outreach

Birmingham, Alabama, 35233, United States

Location

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

Columbia University Irving Medical Center

New York, New York, 10032, United States

Location

Related Publications (2)

  • Schnall R, Jia H, Brin M, Kay ES, Wood OR, Abua J, Batey DS. Efficacy of CHAMPS for Improving Viral Suppression: A Randomised Clinical Trial. AIDS Behav. 2025 Nov;29(11):3703-3713. doi: 10.1007/s10461-025-04811-x. Epub 2025 Jul 10.

  • Wood OR, Schnall R, Kay ES, Jia H, Abua JA, Nichols TK, Olender SA, Mugavero MJ, Batey DS. A community health worker and mobile health app intervention to improve adherence to HIV medication among persons with HIV: the CHAMPS study protocol. BMC Public Health. 2023 May 24;23(1):942. doi: 10.1186/s12889-023-15616-9.

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Results Point of Contact

Title
Rebecca Schnall, PhD, MPH, RN
Organization
Columbia University

Study Officials

  • Rebecca Schnall, PhD, MPH, RN

    Columbia University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Mary Dickey Lindsay Professor of Disease Prevention and Health Promotion

Study Record Dates

First Submitted

September 18, 2020

First Posted

September 24, 2020

Study Start

May 3, 2021

Primary Completion

April 19, 2024

Study Completion

April 19, 2024

Last Updated

February 17, 2025

Results First Posted

February 17, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations